Administration of Activated Charcoal or Sodium Polystyrene Sulfonate (KayexalateTM) as Gastric Decontamination for Lithium Intoxication: An Animal Model
- 1 November 1989
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 65 (5) , 387-389
- https://doi.org/10.1111/j.1600-0773.1989.tb01194.x
Abstract
To determine whether sodium polystyrene sulfonate (SPS; Kayexalate) is effective in decreasing the absorption of lithium (Li) and to test the assumption that Li is poorly adsorbed by activated charcoal, 130 mice were administered an orogastric dose of LiCl (250 mg/kg) followed immediately by orogastric SPS (10 g/kg, SPS Group), activated charcoal (6.7 g/kg, AC Group), or water in an equivalent volume (Control Group). Subgroups of each of the 3 groups were sacrificed at 1, 2, 4 and 8 hr after treatment and serum analyzed for Li concentration. Statistical analyses revealed no overall difference between the AC Group and the Control Group. However, the SPS Group differed from both the Control and the AC Group at each time interval, with Li concentrations significantly lower in the SPS Group. These results demonstrate that; 1) SPS, in this study, effectively reduced serum Li concentrations in an in vivo model, and 2) activated charcoal did not.This publication has 5 references indexed in Scilit:
- Lithium Carbonate IntoxicationArchives of internal medicine (1960), 1989
- In vitro study of lithium carbonate adsorption by activated charcoalJournal of Toxicology: Clinical Toxicology, 1988
- Role of Repeated Oral Doses of Activated Charcoal in Clinical ToxicologyMedical Toxicology, 1986
- Enhancement of theophylline clearance by oral activated charcoalClinical Pharmacology & Therapeutics, 1983
- Acceleration of the Body Clearance of Phenobarbital by Oral Activated CharcoalNew England Journal of Medicine, 1982